Retirement Systems Of Alabama Regeneron Pharmaceuticals, Inc. Transaction History

Retirement Systems Of Alabama

$26.3 Billion
Q3 2024

A detailed history of Retirement Systems Of Alabama transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Retirement Systems Of Alabama holds 23,167 shares of REGN stock, worth $16.9 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

23,167

Previous 23,396 0.98%

Holding current value

$16.9 Million

Previous $24.6 Million 0.96%

% of portfolio

0.09%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 06, 2024	SELL	$1024.09 - $1201.76 $234,516 - $275,203	-229 Reduced 0.98%	23,167 $24.4 Million
Q2 2024 Jul 24, 2024	BUY	$883.2 - $1071.19 $70,656 - $85,695	80 Added 0.34%	23,396 $24.6 Million
Q1 2024 Apr 30, 2024	SELL	$902.69 - $993.35 $266,293 - $293,038	-295 Reduced 1.25%	23,316 $22.4 Million
Q4 2023 Feb 05, 2024	SELL	$775.18 - $881.7 $406,969 - $462,892	-525 Reduced 2.18%	23,611 $20.7 Million
Q3 2023 Nov 06, 2023	SELL	$692.45 - $844.37 $266,593 - $325,082	-385 Reduced 1.57%	24,136 $19.9 Million
Q2 2023 Jul 31, 2023	SELL	$700.03 - $830.35 $5.08 Million - $6.02 Million	-7,255 Reduced 22.83%	24,521 $17.6 Million
Q1 2023 May 01, 2023	SELL	$680.49 - $826.97 $1.72 Million - $2.09 Million	-2,530 Reduced 7.37%	31,776 $26.1 Million
Q4 2022 Feb 06, 2023	SELL	$705.89 - $766.39 $915,539 - $994,007	-1,297 Reduced 3.64%	34,306 $24.8 Million
Q3 2022 Nov 04, 2022	SELL	$573.97 - $724.32 $119,959 - $151,382	-209 Reduced 0.58%	35,603 $24.5 Million
Q2 2022 Aug 03, 2022	BUY	$548.35 - $738.84 $249,499 - $336,172	455 Added 1.29%	35,812 $21.2 Million
Q1 2022 Apr 20, 2022	SELL	$595.12 - $698.43 $36.8 Million - $43.2 Million	-61,872 Reduced 63.64%	35,357 $24.7 Million
Q4 2021 Jan 20, 2022	SELL	$543.48 - $670.97 $578,806 - $714,583	-1,065 Reduced 1.08%	97,229 $61.4 Million
Q3 2021 Nov 03, 2021	SELL	$574.03 - $680.96 $1.27 Million - $1.5 Million	-2,204 Reduced 2.19%	98,294 $59.5 Million
Q2 2021 Jul 21, 2021	SELL	$472.8 - $558.54 $459,088 - $542,342	-971 Reduced 0.96%	100,498 $56.1 Million
Q1 2021 Apr 15, 2021	BUY	$446.73 - $548.2 $26.6 Million - $32.6 Million	59,448 Added 141.47%	101,469 $48 Million
Q4 2020 Jan 26, 2021	SELL	$478.3 - $607.98 $55,004 - $69,917	-115 Reduced 0.27%	42,021 $20.3 Million
Q3 2020 Oct 20, 2020	SELL	$544.75 - $658.21 $539,847 - $652,286	-991 Reduced 2.3%	42,136 $23.6 Million
Q2 2020 Jul 23, 2020	BUY	$493.32 - $643.92 $3.95 Million - $5.16 Million	8,012 Added 22.82%	43,127 $26.9 Million
Q1 2020 Apr 20, 2020	BUY	$336.18 - $494.43 $3,025 - $4,449	9 Added 0.03%	35,115 $17.1 Million
Q4 2019 Jan 28, 2020	BUY	$274.13 - $376.51 $30,702 - $42,169	112 Added 0.32%	35,106 $13.2 Million
Q3 2019 Oct 30, 2019	SELL	$273.46 - $318.39 $459,412 - $534,895	-1,680 Reduced 4.58%	34,994 $9.71 Million
Q2 2019 Jul 09, 2019	BUY	$299.6 - $414.82 $53,628 - $74,252	179 Added 0.49%	36,674 $11.5 Million
Q1 2019 Apr 15, 2019	BUY	$372.08 - $439.57 $282,780 - $334,073	760 Added 2.13%	36,495 $15 Million
Q3 2018 Oct 24, 2018	SELL	$351.14 - $408.51 $181,539 - $211,199	-517 Reduced 1.43%	35,735 $14.4 Million
Q2 2018 Jul 17, 2018	SELL	$284.6 - $344.99 $181,574 - $220,103	-638 Reduced 1.73%	36,252 $12.5 Million
Q1 2018 Apr 27, 2018	SELL	$315.82 - $393.78 $139,592 - $174,050	-442 Reduced 1.18%	36,890 $12.7 Million
Q4 2017 Feb 08, 2018	BUY	$358.63 - $469.95 $21,159 - $27,727	59 Added 0.16%	37,332 $14 Million
Q3 2017 Nov 06, 2017	BUY	$431.38 - $504.0 $16.1 Million - $18.8 Million	37,273	37,273 $16.7 Million

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $78.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Systems Of Alabama with notifications on news.

Account

Retirement Systems Of Alabama Regeneron Pharmaceuticals, Inc. Transaction History